|
|
|
Anemia Clinical Trials, Diagnosis, and Treatment |
|
Thank you for your interest in clinical trials for Anemia.
Please click "Search" to find Anemia clinical trials and medical research
studies or read below for information on Anemia diagnosis and treatment.
If you receive too many study listings you may enter your zip code to find the
locations closest to you.
|
|
|
|
|
Results from Clinical Connection:
|
|
|
|
Your search returned 9 studies:
|
|
|
|
|
Results from other databases:
|
|
Your search returned over 250 results. The top 250 results are being displayed. Please use
additional keywords or decrease the search distance. |
|
Your search returned 250 studies:
- A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease - NCT00830037-46202
Conditions: Chronic Kidney Disease - Iron-Deficiency Anemia
Location: Indianapolis, IN
- A Monoclonal Antibody Conditioning Regimen for Allogeneic Stem Cell Transplant in Patients With Fanconi Anemia. - NCT00058565-77030A
Conditions: Fanconi's Anemia
Location: Houston, TX
- A Monoclonal Antibody Conditioning Regimen for Allogeneic Stem Cell Transplant in Patients With Fanconi Anemia. - NCT00058565-77030B
Conditions: Fanconi's Anemia
Location: Houston, TX
- A Monoclonal Antibody Conditioning Regimen for Allogeneic Stem Cell Transplant in Patients With Fanconi Anemia. - NCT00058565-77030C
Conditions: Fanconi's Anemia
Location: Houston, TX
- A Phase II Study of Umbilical Cord Blood Transplantation - NCT00676806-02111
Conditions: Leukemia - Lymphoma - Multiple Myeloma - Aplastic Anemia
Location: Boston, MA
- A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R Agonist), Eltrombopag, in Aplastic Anemia Patients With Immunosuppressive-Therapy Refractory Thrombocytopenia - NCT00922883-20892
Conditions: Anemia, Aplastic - Anemia, Hypoplastic - Thrombocytopenia
Location: Bethesda, MD
- A Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia - NCT01179217-11215
Conditions: Sickle Cell Anemia - Sickle ß0-Thalassemia
Location: Brooklyn, NY
- A Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia - NCT01179217-11238
Conditions: Sickle Cell Anemia - Sickle ß0-Thalassemia
Location: Brooklyn, NY
- A Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia - NCT01179217-36617
Conditions: Sickle Cell Anemia - Sickle ß0-Thalassemia
Location: Mobile, AL
- A Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia - NCT01179217-60612
Conditions: Sickle Cell Anemia - Sickle ß0-Thalassemia
Location: Chicago, IL
- A Safety Study of Pentoxifylline for the Treatment of Anemia - NCT01102218-38478
Conditions: End Stage Renal Disease
Location: Columbia, TN
- A Safety Study of Pentoxifylline for the Treatment of Anemia - NCT01102218-38801
Conditions: End Stage Renal Disease
Location: Tupelo, MS
- A Safety Study of Pentoxifylline for the Treatment of Anemia - NCT01102218-39601
Conditions: End Stage Renal Disease
Location: Brookhaven, MS
- A Safety Study of Pentoxifylline for the Treatment of Anemia - NCT01102218-49007
Conditions: End Stage Renal Disease
Location: Kalamazoo, MI
- A Safety Study of Pentoxifylline for the Treatment of Anemia - NCT01102218-60616
Conditions: End Stage Renal Disease
Location: Chicago, IL
- A Safety Study of Pentoxifylline for the Treatment of Anemia - NCT01102218-63074
Conditions: End Stage Renal Disease
Location: St. Ann, MO
- A Safety Study of Pentoxifylline for the Treatment of Anemia - NCT01102218-63376
Conditions: End Stage Renal Disease
Location: St. Peters, MO
- A Safety Study of Pentoxifylline for the Treatment of Anemia - NCT01102218-75039
Conditions: End Stage Renal Disease
Location: Irving, TX
- A Safety Study of Pentoxifylline for the Treatment of Anemia - NCT01102218-75701
Conditions: End Stage Renal Disease
Location: Tyler, TX
- A Safety Study of Pentoxifylline for the Treatment of Anemia - NCT01102218-89120
Conditions: End Stage Renal Disease
Location: Las Vegas, NV
- A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q - NCT01029262-03756
Conditions: Anemia
Location: Lebanon, NH
- A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q - NCT01029262-07601
Conditions: Anemia
Location: Hackensack, NJ
- A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q - NCT01029262-53226
Conditions: Anemia
Location: Milwaukee, WI
- A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Low Risk Myelodysplastic Syndrome (MDS) Without Del 5Q - NCT01029262-77030
Conditions: Anemia
Location: Houston, TX
- A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. - NCT00442702-02903
Conditions: Anemia
Location: Providence, RI
- A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. - NCT00442702-11501
Conditions: Anemia
Location: Mineola, NY
- A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. - NCT00442702-14127
Conditions: Anemia
Location: Orchard Park, NY
- A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. - NCT00442702-24153
Conditions: Anemia
Location: Salem, VA
- A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. - NCT00442702-26506
Conditions: Anemia
Location: Morgantown, WV
- A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. - NCT00442702-27609
Conditions: Anemia
Location: Raleigh, NC
- A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. - NCT00442702-30901
Conditions: Anemia
Location: Augusta, GA
- A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. - NCT00442702-33313
Conditions: Anemia
Location: Lauderdale Lakes, FL
- A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. - NCT00442702-37404
Conditions: Anemia
Location: Chattanooga, TN
- A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. - NCT00442702-68114
Conditions: Anemia
Location: Omaha, NE
- A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. - NCT00442702-91344
Conditions: Anemia
Location: Granada Hills, CA
- A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis. - NCT00442702-97045
Conditions: Anemia
Location: Oregon City, OR
- A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency Anemia - NCT01114204-02421
Conditions: Iron Deficiency Anemia
Location: Lexington, MA
- A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia - NCT01114139-02421
Conditions: Iron Deficiency Anemia
Location: Lexington, MA
- A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Subjects With Dialysis Dependent Chronic Kidney Disease - NCT01155375-02421
Conditions: Iron Deficiency Anemia
Location: Lexington, MA
- A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Subjects With Nondialysis-Dependent Chronic Kidney Disease - NCT01155388-02421
Conditions: Iron Deficiency Anemia - Nondialysis Dependent Chronic Kidney Disease
Location: Lexington, MA
- Alemtuzumab to Treat Severe Aplastic Anemia - NCT00195624-20892
Conditions: Relapsed or Refractory Severe Aplastic Anemia - Severe Aplastic Anemia
Location: Bethesda, MD
- Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders - NCT00301834-53792
Conditions: Congenital Amegakaryocytic Thrombocytopenia - Diamond-Blackfan Anemia - Leukemia - Myelodysplastic Syndromes - Severe Congenital Neutropenia
Location: Madison, WI
- Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders - NCT00301834-94115
Conditions: Congenital Amegakaryocytic Thrombocytopenia - Diamond-Blackfan Anemia - Leukemia - Myelodysplastic Syndromes - Severe Congenital Neutropenia
Location: San Francisco, CA
- Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells - NCT011
Conditions: Severe Aplastic Anemia - MDS (Myelodysplastic Syndrome)
Location: Bethesda, MD
- Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia - NCT00578903-77030A
Conditions: Aplastic Anemia
Location: Houston, TX
- Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia - NCT00578903-77030B
Conditions: Aplastic Anemia
Location: Houston, TX
- Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia - NCT00578266-55905
Conditions: Anemia, Aplastic
Location: Rochester, MN
- Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs - NCT00957931-35233
Conditions: Sickle Cell Disease - Thalassemia - Diamond-Blackfan Anemia
Location: Birmingham, AL
- Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs - NCT00957931-55455
Conditions: Sickle Cell Disease - Thalassemia - Diamond-Blackfan Anemia
Location: Minneapolis, MN
- An Open-Label, Single-Arm Pilot Study of the Efficacy of Erythropoietin Alfa in Improving Peak Oxygen Consumption in Elderly Subjects With Unexplained Anemia - NCT00954486-60637
Conditions: Anemia
Location: Chicago, IL
- An Open-Label, Single-Arm Pilot Study of the Efficacy of Erythropoietin Alfa in Improving Peak Oxygen Consumption in Elderly Subjects With Unexplained Anemia - NCT00954486-94304
Conditions: Anemia
Location: Palo Alto, CA
- An Open-Label, Single-Arm Pilot Study of the Efficacy of Erythropoietin Alfa in Improving Peak Oxygen Consumption in Elderly Subjects With Unexplained Anemia - NCT00954486-94305
Conditions: Anemia
Location: Stanford, CA
- Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF) - NCT00286182-10034
Conditions: Anemia
Location: New York, NY
- Anemia in the Elderly - NCT00640172-84132
Conditions: Anemia
Location: Salt Lake City, UT
- Anemia in the Elderly - NCT00640172-94304
Conditions: Anemia
Location: Palo Alto, CA
- Anemia in the Elderly - NCT00640172-94305
Conditions: Anemia
Location: Stanford, CA
- Anemia Treatment for Advanced NSCLC Patients Receiving Chemotherapy - NCT00858364-
Conditions: Non-small Cell Lung Cancer - Anemia - Cancer - Lung Cancer
Location: Green Bay, WI
- Antioxidant Therapy to Reduce Inflammation in Sickle Cell Disease - NCT01054768-94609
Conditions: Anemia, Sickle Cell
Location: Oakland, CA
- Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients - NCT00029731-94609
Conditions: Anemia, Sickle Cell - Pneumonia
Location: Oakland, CA
- Assess the Feasibility and Safety of Granulocyte Colony Stimulating Factor (GCSF) Mobilization of CD34+ Hematopoietic Progenitor Cells in Patients With Betathalassemia Major - NCT00658385-10065
Conditions: Beta Thalassemia Major - Congenital Anemias
Location: New York, NY
- Chemotherapy, Antithymocyte Globulin, Total-Body Irradiation, and a Donor Umbilical Cord Blood Transplant and Donor Stem Cell Transplant in Treating Patients With Severe Aplastic Anemia or Myelodysplastic Syndromes - NCT00608413-20892
Conditions: Leukemia - Myelodysplastic Syndromes - Nonmalignant Neoplasm
Location: Bethesda, MD
- Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes - NCT00102245-20892
Conditions: Hemoglobinopathies - Hemolysis - Iron Deficiency and Overload - Anemias
Location: Bethesda, MD
- Clinical Importance of Treating Iron Overload in Sickle Cell Disease - NCT00981370-90027A
Conditions: Anemia, Sickle Cell - Transfusion Hemochromatosis
Location: Los Angeles, CA
- Clinical Importance of Treating Iron Overload in Sickle Cell Disease - NCT00981370-90027B
Conditions: Anemia, Sickle Cell - Transfusion Hemochromatosis
Location: Los Angeles, CA
- Collection and Storage of Umbilical Cord Stem Cells for Treatment of Sickle Cell Disease - NCT00012545-20892
Conditions: Healthy - Sickle Cell Anemia
Location: Bethesda, MD
- Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia - NCT00054236-44024
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases
Location: Cleveland, OH
- Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia - NCT00054236-44060
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases
Location: Cleveland, OH
- Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia - NCT00054236-44106
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases
Location: Cleveland, OH
- Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia - NCT00054236-44121
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases
Location: Cleveland, OH
- Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia - NCT00054236-44122
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases
Location: Cleveland, OH
- Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia - NCT00054236-44130
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases
Location: Cleveland, OH
- Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia - NCT00054236-44145
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases
Location: Cleveland, OH
- Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia - NCT00054236-44708
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases
Location: Cleveland, OH
- Conservative Versus Liberal Red Cell Transfusion in Myocardial Infarction Trial: The CRIT Pilot - NCT00126334-
Conditions: Myocardial Infarction - Anemia
Location: Durham, NC
- Conservative Versus Liberal Red Cell Transfusion in Myocardial Infarction Trial: The CRIT Pilot - NCT00126334-20010A
Conditions: Myocardial Infarction - Anemia
Location: Washington, DC
- Conservative Versus Liberal Red Cell Transfusion in Myocardial Infarction Trial: The CRIT Pilot - NCT00126334-20010B
Conditions: Myocardial Infarction - Anemia
Location: Washington, DC
- Cyclophosphamide and Antithymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing a Donor Bone Marrow Transplant - NCT00343785-07601
Conditions: Graft Versus Host Disease - Nonmalignant Neoplasm
Location: Hackensack, NJ
- Cyclophosphamide and Antithymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing a Donor Bone Marrow Transplant - NCT00343785-53226
Conditions: Graft Versus Host Disease - Nonmalignant Neoplasm
Location: Milwaukee, WI
- Cyclophosphamide and Antithymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing a Donor Bone Marrow Transplant - NCT00343785-84132
Conditions: Graft Versus Host Disease - Nonmalignant Neoplasm
Location: Salt Lake City, UT
- Cyclophosphamide and Antithymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing a Donor Bone Marrow Transplant - NCT00343785-94609
Conditions: Graft Versus Host Disease - Nonmalignant Neoplasm
Location: Oakland, CA
- Cyclophosphamide and Antithymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing a Donor Bone Marrow Transplant - NCT00343785-98109A
Conditions: Graft Versus Host Disease - Nonmalignant Neoplasm
Location: Seattle, WA
- Cyclophosphamide and Antithymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing a Donor Bone Marrow Transplant - NCT00343785-98109B
Conditions: Graft Versus Host Disease - Nonmalignant Neoplasm
Location: Seattle, WA
- Cyclophosphamide, Alemtuzumab, Total-Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Severe Aplastic Anemia - NCT00598221-77030A
Conditions: Nonmalignant Neoplasm
Location: Houston, TX
- Cyclophosphamide, Alemtuzumab, Total-Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Severe Aplastic Anemia - NCT00598221-77030B
Conditions: Nonmalignant Neoplasm
Location: Houston, TX
- Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant - NCT00354419-98104
Conditions: Nonmalignant Neoplasm
Location: Seattle, WA
- Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant - NCT00354419-98109
Conditions: Nonmalignant Neoplasm
Location: Seattle, WA
- Cyclophosphamide, Fludarabine, and Antithymocyte Globulin Followed By Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia - NCT00630253-55455
Conditions: Fanconi Anemia
Location: Minneapolis, MN
- Delayed Cord Clamping in Premature Infants - NCT01018576-95817
Conditions: Hypothermia - Anemia
Location: Sacramento, CA
- Diamond Blackfan Anemia Registry (DBAR) - NCT00106015-11040
Conditions: Anemia - Blood Disease
Location: New Hyde Park, NY
- Donor Stem Cell Transplant in Treating Patients With Fanconi's Anemia - NCT00453388-98109A
Conditions: Fanconi Anemia - Graft Versus Host Disease - Leukemia - Myelodysplastic Syndromes
Location: Seattle, WA
- Donor Stem Cell Transplant in Treating Patients With Fanconi's Anemia - NCT00453388-98109B
Conditions: Fanconi Anemia - Graft Versus Host Disease - Leukemia - Myelodysplastic Syndromes
Location: Seattle, WA
- Effectiveness of a Computerized Tool (PAINRelieveIt) to Help Manage Pain Related to Sickle Cell Disease - NCT00600665-60612
Conditions: Anemia, Sickle Cell - Hemoglobin SC Disease
Location: Chicago, IL
- Effects Of Darbepoetin On Vascular Repair Mechanisms In Kidney Disease The DARBEPC Study - NCT00396123-48109
Conditions: Chronic Kidney Disease - Anemia
Location: Ann Arbor, MI
- Effects of Erythropoietin on Cerebral Vascular Dysfunction and Anemia in Traumatic Brain Injury - NCT00313716-77030
Conditions: Anemia - Traumatic Brain Injury
Location: Houston, TX
- Effects of Erythropoietin on Cerebral Vascular Dysfunction and Anemia in Traumatic Brain Injury - NCT00313716-77074
Conditions: Anemia - Traumatic Brain Injury
Location: Houston, TX
- Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA) - NCT00982007-19403
Conditions: Iron Deficiency Anemia
Location: Valley Forge, PA
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-02115
Conditions: Anemia
Location: Boston, MA
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-07503
Conditions: Anemia
Location: Paterson, NJ
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-07601
Conditions: Anemia
Location: Hackensack, NJ
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-11040
Conditions: Anemia
Location: New York, NY
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-11201
Conditions: Anemia
Location: Brooklyn, NY
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-13210
Conditions: Anemia
Location: Syracuse, NY
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-17033
Conditions: Anemia
Location: Hershey, PA
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-23507
Conditions: Anemia
Location: Norfolk, VA
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-27858
Conditions: Anemia
Location: Greenville, NC
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-32806
Conditions: Anemia
Location: Orlando, FL
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-33609
Conditions: Anemia
Location: Tampa, FL
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-36604
Conditions: Anemia
Location: Mobile, AL
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-38105
Conditions: Anemia
Location: Memphis, TN
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-44308
Conditions: Anemia
Location: Akron, OH
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-45404
Conditions: Anemia
Location: Dayton, OH
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-60614
Conditions: Anemia
Location: Chicago, IL
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-73104
Conditions: Anemia
Location: Oklahoma City, OK
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-76104
Conditions: Anemia
Location: Fort Worth, TX
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-77030
Conditions: Anemia
Location: Houston, TX
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-90027
Conditions: Anemia
Location: Los Angeles, CA
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-92868
Conditions: Anemia
Location: Orange, CA
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-94304
Conditions: Anemia
Location: Stanford, CA
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-94609
Conditions: Anemia
Location: Oakland, CA
- Evaluating an Educational Program Geared for Parents and Aimed at Improving Academic Success in Children With Sickle Cell Disease - NCT00860782-33131
Conditions: Hemoglobin SC Disease - Anemia, Sickle Cell
Location: Miami, FL
- Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy Volunteers - NCT00899795-97239
Conditions: Leukemia - Myelodysplastic Syndromes
Location: Portland, OR
- Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function - NCT00981045-19403
Conditions: Iron Deficiency Anemia - Impaired Renal Function
Location: Valley Forge, PA
- Fanconi Anemia Transplant Lacking Genotypically Identical Donor - NCT00850317-02115
Conditions: Fanconi Anemia
Location: Boston, MA
- Ferumoxytol Compared to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease - NCT01052779-02421
Conditions: Iron Deficiency - Anemia - Kidney Disease
Location: Lexington, MA
- Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia - NCT01114217-02421
Conditions: Iron Deficiency Anemia
Location: Lexington, MA
- Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By Donor Bone Marrow Transplant in Treating Patients With Sickle Cell Anemia - NCT00489281-21231
Conditions: Sickle Cell Disease
Location: Baltimore, MD
- Fludarabine, Melphalan, Total-Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders - NCT00856388-14263
Conditions: Chronic Myeloproliferative Disorders - Fanconi Anemia - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases - Nonmalignant Neoplasm - Paroxysmal Nocturnal Hemoglobinuria
Location: Buffalo, NY
- Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation in Aplastic Anemia - NCT00474747-77030
Conditions: Aplastic Anemia
Location: Houston, TX
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-02114A
Conditions: Anemia, Aplastic
Location: Boston, MA
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-02114B
Conditions: Anemia, Aplastic
Location: Boston, MA
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-07601
Conditions: Anemia, Aplastic
Location: Hackensack, NJ
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-10021
Conditions: Anemia, Aplastic
Location: New York City, NY
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-14263
Conditions: Anemia, Aplastic
Location: Buffalo, NY
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-20010
Conditions: Anemia, Aplastic
Location: Washington, DC
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-23298
Conditions: Anemia, Aplastic
Location: Richmond, VA
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-27705
Conditions: Anemia, Aplastic
Location: Durham, NC
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-30322
Conditions: Anemia, Aplastic
Location: Atlanta, GA
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-32610
Conditions: Anemia, Aplastic
Location: Gainesville, FL
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-43205
Conditions: Anemia, Aplastic
Location: Columbus, OH
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-45229
Conditions: Anemia, Aplastic
Location: Cincinnati, OH
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-48109
Conditions: Anemia, Aplastic
Location: Ann Arbor, MI
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-55455
Conditions: Anemia, Aplastic
Location: Minneapolis, MN
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-57105
Conditions: Anemia, Aplastic
Location: Sioux Falls,
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-75235
Conditions: Anemia, Aplastic
Location: Dallas, TX
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-76104
Conditions: Anemia, Aplastic
Location: Fort Worth, TX
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-77030
Conditions: Anemia, Aplastic
Location: Houston, TX
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-78229
Conditions: Anemia, Aplastic
Location: San Antonio, TX
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-85016
Conditions: Anemia, Aplastic
Location: Phoenix, AZ
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-90027
Conditions: Anemia, Aplastic
Location: Los Angeles, CA
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-90095
Conditions: Anemia, Aplastic
Location: Los Angeles, CA
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-91010
Conditions: Anemia, Aplastic
Location: Duarte, CA
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-94305
Conditions: Anemia, Aplastic
Location: Stanford, CA
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-97239
Conditions: Anemia, Aplastic
Location: Portland, OR
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-98109
Conditions: Anemia, Aplastic
Location: Seattle, WA
- Gene Function in Bone Marrow Cells From Patients With Fanconi Anemia and From Healthy Participants - NCT00896740-97239
Conditions: Fanconi Anemia
Location: Portland, OR
- Hematopoietic Stem Cell Transplant for Fanconi Anemia - NCT01071239-53226
Conditions: Fanconi Anemia
Location: Milwaukee, WI
- Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine - NCT00987480-
Conditions: Aplastic Anemia - Leukemia - Myelodysplastic Syndrome
Location: Milwaukee, WI
- Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine - NCT00987480-02115
Conditions: Aplastic Anemia - Leukemia - Myelodysplastic Syndrome
Location: Boston, MA
- Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine - NCT00987480-10065A
Conditions: Aplastic Anemia - Leukemia - Myelodysplastic Syndrome
Location: New York, NY
- Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine - NCT00987480-10065B
Conditions: Aplastic Anemia - Leukemia - Myelodysplastic Syndrome
Location: New York, NY
- Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine - NCT00987480-45229
Conditions: Aplastic Anemia - Leukemia - Myelodysplastic Syndrome
Location: Cincinnati, OH
- Hematopoietic Stem Cell Transplantation for Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using Total Body Irradiation, Cyclophosphamide and Fludarabine - NCT00595127-10065
Conditions: Fanconi Anemia
Location: New York, NY
- Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment - NCT00944749-20892
Conditions: Anemia, Aplastic - Anemia, Hypoplastic
Location: Bethesda, MD
- Impact of Host Iron Status and Iron Supplement Use on Erythrocytic Stage of Plasmodium Falciparum - NCT01027663-27599
Conditions: Iron Deficiency Anemia - Malaria
Location: Chapel Hill, NC
- Impact of Maternal Iron Status on Neonatal Iron Status and Auditory Brainstem Response in the Newborn - NCT01019902-14642
Conditions: Anemia
Location: Rochester, NY
- Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias - NCT00061568-20892
Conditions: Congenital Hemolytic Anemia - Diamond-Blackfan Anemia
Location: Bethesda, MD
- Intelligent Control Approach to Anemia Management - NCT00572533-40202
Conditions: End-Stage Renal Disease
Location: Louisville, KY
- Intravenous Gammaglobulin for Sickle Cell Pain Crises - NCT00644865-10029
Conditions: Sickle Cell Anemia
Location: New York, NY
- Iron Prophylaxis for Anemia in Infants With Cyanotic Congenital Heart Disease - NCT00459225-30312
Conditions: Anemia
Location: Atlanta, GA
- IV Iron for the Anemia of Traumatic Critical Illness - NCT01180894-
Conditions: Trauma - ICU Anemia
Location: Seattle, WA
- IV Iron for the Anemia of Traumatic Critical Illness - NCT01180894-10065
Conditions: Trauma - ICU Anemia
Location: New York, NY
- IV Iron for the Anemia of Traumatic Critical Illness - NCT01180894-21287
Conditions: Trauma - ICU Anemia
Location: Baltimore, MD
- Lenalidomide in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma - NCT00439231-20892
Conditions: Chronic Lymphocytic Anemia - Small Lymphocytic Lymphoma
Location: Bethesda, MD
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-01805
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Burlington, MA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-01844
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Methuen, MA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-03431
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Keene, NH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-06050
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: New Britain, CT
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-07018
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: East Orange, NJ
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-07112
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Newark, NJ
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-08043
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Voorhees, NJ
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-10016
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: New York, NY
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-10461
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Bronx, NY
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-10466
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Bronx, NY
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-11501
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Mineola, NY
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-12801A
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Glens Falls, NY
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-12801B
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Glens Falls, NY
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-13057
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: East Syracuse, NY
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-16801
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: State College, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-16803
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: State College, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-17033
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Hershey, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-17044
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Lewistown, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-17522
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Ephrata, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-17822
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Danville, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-18201
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Hazleton, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-18711
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Wilkes-Barre, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-19001
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Abington, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-19010
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Bryn Mawr, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-19063
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Media, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-19096A
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Wynnewood, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-19096B
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Wynnewood, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-19104
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Philadelphia, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-19107
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Philadelphia, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-19141
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Philadelphia, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-19301
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Paoli, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-19460
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Phoenixville, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-19612
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Reading, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-19713
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Newark, DE
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-19958
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Lewes, DE
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-21201
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Baltimore, MD
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-21231
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Baltimore, MD
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-21921
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Elkton MD, MD
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-22401
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Fredericksburg, VA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-22908
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Charlottesville, VA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-24115
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Martinsville, VA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-24541
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Danville, VA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-25702
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Huntington, WV
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-26506
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Morgantown, WV
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-27534
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Goldsboro, NC
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-29615
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Greenville, SC
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-32207
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Jacksonville, FL
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-32224
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Jacksonville, FL
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-33021
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Hollywood, FL
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-33136
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Miami, FL
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-33612
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Tampa, FL
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-35294
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Birmingham, AL
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-37916
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Knoxville, TN
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-39534
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Kessler AFB, MS
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-39581
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Pascagoula, MS
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-41101
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Ashland, KY
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43402
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Bowling Green, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43410
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Clyde, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43537A
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Maumee, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43537B
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Maumee, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43560
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Sylvania, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43567
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Wauseon, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43606
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Toledo, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43608
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Toledo, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43614
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Toledo, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43616A
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Oregon, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43616B
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Oregon, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43617
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Toledo, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43623A
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Toledo, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43623B
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Toledo, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-44035A
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Elyria, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-44035B
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Elyria, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-44109
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Cleveland, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-44708
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Canton, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-44710
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Canton, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-44857
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Norwalk, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-44870
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Sandusky, OH
|
|
|
|
|
Didn't find what you were looking for? Try these alternatives:
Become A Member: To be notified of upcoming clinical trials in your
area please create a free member account.
Browse Studies: If you would like to browse all featured clinical trials
please Browse Studies.
Message Board: Join the discussion in our Health
and Clinical Trials Message Board.
|
|
|